Machine learning, predictive models, and computational biology—how AI is changing discovery workflows and probability of success.
UnitedHealth Group is making a substantial $3 billion investment in artificial intelligence technologies, poised to transform healthcare delivery with profound implications for patient care and operational efficiency.
UnitedHealth Group is making a substantial $3 billion investment in artificial intelligence technologies, poised to transform healthcare delivery with profound implications for patient care and operational efficiency.
READ MORE
Successful healthcare AI startups are those that integrate seamlessly into clinical workflows, develop proprietary datasets, and swiftly strategize their market approach.
Jimini Health has secured a $17 million funding round led by multiple prominent venture firms to advance its clinician-supervised AI platform in behavioral health, aiming to support mental health treatment with innovative technology.
Mass General Brigham carefully monitors the real-world performance of AI tools before scaling them system-wide, ensuring efficacy and safety in healthcare environments.
Lilly's strategic collaboration with Insilico Medicine marks a major advancement in leveraging artificial intelligence for drug development, highlighted by a deal worth up to $2.75 billion.
Artificial intelligence promises to enhance healthcare access through accurate risk prediction, but its success depends on coordinated human intervention and planning.
UnitedHealthcare has launched Avery, an AI assistant designed to help members better manage their benefits and navigate healthcare services, supported by live assistance.
Wayne General Hospital in rural Mississippi is leveraging AI-powered digital stethoscopes to detect heart conditions earlier, addressing limited specialist access and improving patient outcomes.
With a massive $787 million funding round, Earendil Labs is set to accelerate its AI-powered platform for biologics design, focusing on innovative therapies including anti-inflammatory agents partnered with major pharma firms.
Utah's piloting of Doctronic's autonomous prescription refill AI highlights the promise and peril of AI in healthcare, amid concerns about safety and regulatory challenges.
Katie Jacobs Stanton of Moxxie Ventures outlines key criteria for evaluating healthcare AI startups, focusing on industry expertise, product differentiation, and practical distribution strategies.
